Optimizing disease risk stratification and clinical outcomes in chronic lymphocytic leukemia 2025

A better understanding of disease biology and implementation of targeted agents have set a paradigm shift in motion in chronic lymphocytic leukemia (CLL) and rechallenged key principles in previous management strategies. In this issue of Magazine of European Medical Oncology (MEMO), we tackle three hot topics with novel clinical trial data and discuss their potential implications for clinical practice. …